George Abe

George Abe has a comprehensive work experience spanning multiple industries and roles. In their most recent position as the Chief Operating Officer at REALM IDx, Inc. since August 2021, they oversee operations for the company. Prior to that, George served as a Member of the Board of Directors at 149 Medical Inc since August 2020.

From October 2017 to August 2021, George worked as the Chief Business and Strategy Officer at Invicro, where they played a crucial role in shaping the company's business and strategic direction. Before Invicro, George was the Managing Partner at Dromaeo Partners LLC, where they held this position from an unspecified date in 2014 until August 2021.

Additionally, George served as a Member of the Board of Trustees at Wentworth Institute of Technology from 2014 to 2020. George also held the position of CEO at Cubresa Inc. from an unspecified date in 2015 until 2017 and was the President at Beryllium (formerly Emerald Bio) from an unspecified date in 2011 until 2014.

George Abe's earlier experiences include holding the role of Senior Vice President Tissue Imaging at Caliper Life Sciences from an unspecified date in 2010 until 2011. George was also a Member of the Board of Directors at Candela Medical from an unspecified date in 2003 until 2010.

Furthermore, George's notable achievement includes their tenure as the President and CEO at Cambridge Research & Instrumentation (CRi) from an unspecified date in 2002 until 2010. During this time, they successfully transformed CRi into a leading multiplexed biomarker imaging systems company before its acquisition by Caliper (Perkin Elmer) in December 2010.

George Abe has a Bachelor of Science degree in Engineering from Trinity College-Hartford. George later pursued a Master of Science degree in Engineering from the University of Connecticut. Additionally, George attended the MIT Sloan School of Management's Greater Boston Executive Program, where they studied Management.